Search This Blog

Tuesday, February 18, 2020

bluebird bio EPS misses by $0.25, beats on revenue

bluebird bio (NASDAQ:BLUE): Q4 GAAP EPS of -$4.04 misses by $0.25.
Revenue of $9.99M (-48.1% Y/Y) beats by $1.76M.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)